Sherise Rogers

Sherise Rogers, MD, MPH

Assistant Professor

Department: MD-HEMATOLOGY/ONCOLOGY
Business Phone: (352) 273-7832

About Sherise Rogers

Sherise C. Rogers, M.D., M.P.H., received her bachelor’s degree from Cornell University in 2009 in Human Development with a minor in Biological Sciences. She then obtained her Medical Doctorate in 2014 and Master in Public Health in 2015 from New York Medical College.

Dr. Rogers completed her Internal Medicine Residency at Stony Brook University Medical Center in New York in 2017. She completed her Hematology & Oncology Fellowship at The Ohio State University Medical Center where she also served as Wellness Chief Fellow in 2020. Aside from her educational achievements, Dr. Rogers has a passion for mentoring and has completed many professional development programs such as the Physician Leadership Academy and Medical Journalism elective at the ABC News Medical Unit in New York City.

Her peer reviewed publications and presentations have concentrations in gastrointestinal oncology, diversity and inclusion, physician wellness and strategies to address burnout among hematology and oncology trainees. She is a member of many professional memberships such as the ASCO and AACR.

Dr. Rogers’ area of clinical and research focus are gastrointestinal malignancies with a special interest in pancreatic cancer, the microbiome, circulating tumor DNA and cancer disparities.

Teaching Profile

Courses Taught
2021-2022
BMS6816 Cancer Bio Clin Oncol

Clinical Profile

Subspecialties
  • Hematology and Oncology
Areas of Interest
  • Colorectal cancer
  • Esophageal cancer
  • Liver cancer – hepatocellular carcinoma
  • Pancreatic cancer
  • Stomach cancer

Research Profile

Areas of Interest
  • Hematology and Oncology

Publications

2021
Immunotherapy Management in Special Cancer Patient Populations.
JCO oncology practice. 17(5):240-245 [DOI] 10.1200/OP.20.00996. [PMID] 33710933.

Grants

Oct 2021 ACTIVE
Intestinal Microbiota Associations with Toxicity and Outcomes in Patients with Pancreatic Cancer during Neoadjuvant Curative Treatment
Role: Principal Investigator
Funding: BRISTOL-MYERS SQUIBB FOUNDATION
Jun 2020 ACTIVE
A Randomized Phase II Study of Gemcitabine and Nab-Paclitaxel Compared with 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan in Older Patients with Treatment Na?ve Metastatic Pancreatic Cancer (GIANT)
Role: Principal Investigator
Funding: NRG ONCOLOGY FOU via NATL INST OF HLTH NCI
Jul 2019 – Jun 2022
UF Health Cancer Center Pilot Projects funded by UF Foundation Allocated Funds
Role: Project Manager
Funding: UF FOUNDATION
Sep 2018 ACTIVE
2/3 Florida-California Cancer Research, Education & Engagement (CaRE2) Health Equity Center
Role: Other
Funding: NATL INST OF HLTH NCI

Education

Masters Degree, Public Health
2010-2015 · New York Medical College
Medical Degree
2010-2014 · New York Medical College
Bachelor Degree, Human Development
2005-2009 · Cornell University

Contact Details

Phones:
Business:
(352) 273-7832
Administrative Support AST III:
Addresses:
Business Mailing:
PO Box 100278
GAINESVILLE FL 32610